Final-Program-ATS-2023-AP.vp

SUNDAY • MAY 21

51

Abnormalities in Persons Living With HIV/ S. Chang-Huang, San Francisco, CA 410 Clinical Risk Factors for Unintentional Weight Loss in Participants With COPD Are Present Five Years Before Its Onset/ J.W. Chiles, Birmingham, AL 411 Compound Sarcopenia in Hospitalized COPD Patients Worsens Outcomes in Relation to Age/ A. Attaway, Cleveland, OH 412 Classifying Physical Conditioning Using Remote Monitoring in Chronic Obstructive Pulmonary Disease/ A. Balasubramanian, Baltimore, MD 413 Sleep Disordered Breathing Is Associated With Cognitive Impairment in Chronic Obstructive Pulmonary Disease (COPD)/ C. Buri-Nagua, Baltimore, MD 414 Anemia Trajectories Are Associated With Risk for Adverse Outcomes in COPD/ Y. Kunitomo, Baltimore, MD 415 Outcomes of Chronic Obstructive Pulmonary Disease (COPD) Exacerbations in Patients With Lung Cancer: A Nationwide Inpatient Analysis/ V. Deenadayalan, Chicago, IL 416 The Burden of Atrial Fibrillation, Supraventricular and Ventricular Arrhythmias in COPD Exacerbation Hospitalizations/ A. Aboelnasr, Cincinnati, OH 417 Cardiovascular Complications According to Inhaler Therapy in Chronic Obstructive Pulmonary Disease/ J.H. Park, Suwon, Korea, Republic of 418 COPD Phenotypes: Out-of-Proportion Pulmonary Hypertension in Emphysema Vs. Non-emphysema COPD/ J.D. Rivera Robles, Weston, FL 419 Right Ventricle Diastolic Diameter Can Be Used as a Predictor of Adverse Outcomes in COPD Patients/ F.P.G. Rizzatti, Sao Paulo, Brazil 420 Individuals With the PI*MZ and PI*MS Genotypes Have Similar Prevalence of Liver and Lung Disease in an EHR-based Cohort Study/ V. Tejwani, Cleveland, OH 421 Stability and Predictive Value of Persistent Airflow Limitation in Patients With Physician-diagnosed COPD and/or Asthma in the NOVELTY Study/ R.A. Del Olmo Sansone, Buenos Aires, Argentina 422 Association Between Oral Health and Airflow Limitation: Analysis Using a Nationwide Survey in Korea/ S.-H. Kim, Cheongju-si, Korea, Republic of 423 Chronic Bronchitis Is Associated With Pulmonary Artery Enlargement in Smokers With and Without COPD: An Analysis of the COPDGene Study/ F.A. Laghi, Philadelphia, PA 424 Clinical Significance of Chronic Bronchitis in Different Racial Groups/ J.Y. Choi, Incheon, Korea, Republic of

824 A Proteomic Signature to Predict Rapidly Progressive Idiopathic Pulmonary Fibrosis/ J. Oldham, Ann Arbor, MI 825 Effects of Nintedanib on Circulating Biomarkers in Patients With Progressive Pulmonary Fibrosis: Subgroup Analyses of the INBUILD Trial/ T.M. Maher, Los Angeles, CA

CLINICAL • TRANSLATIONAL POSTER DISCUSSION SESSION

A24

COPD PHENOTYPES: LOOKING OUTSIDE THE LUNG

9:00 a.m. - 11:00 a.m.

Walter E. Washington Convention Center Room 151 A (Street Level)

Poster Viewing

9:00-9:45 9:45-11:00

Discussion

Chairing: L. Vanfleteren, MD, PhD, Gothenburg, Sweden D. Chandra, MD, Pittsburgh, PA A. Balasubramanian, MD, MHS, Baltimore, MD 401 Use of the Wnt/ß-catenin Activator Lithium Is Associated With Less Emphysema in Smokers/ K.O. Allbright, Pittsburgh, PA 402 Genetic Risk for Body Mass and Mortality in COPD/ J. Zhang, Boston, MA 403 Interaction of Diabetes and Lung Diffusing Capacity With Survival in a Tobacco Exposed Cohort/ J.C. Hulbert, Pittsburgh, PA 404 Elevated Adiponectin Levels Associate With Hip Bone Mineral Density Loss in Current and Former Smokers/ V. Babu, Pittsburgh, PA 405 Intermuscular Adipose Tissue Mass Is Associated With Muscle Weakness in Smokers With COPD/ R.H. Zou, Pittsburgh, PA 406 The Association Between Metformin Use and Respiratory-related Outcomes After Overlap Weighting/ Y. Li, Aurora, CO 407 Associations of Low Skeletal Muscle Quantity With Coronary Artery Calcification and Low Bone Mineral Density on Computed Tomography in Normal Weight Patients With COPD/ S. Terada, Kyoto, Japan 408 Frailty Is a Risck Factor for Chronic Obstructive Pulmonary Disease Hospitalization/ A.C.G. Ferreira, Goiânia, Brazil 409 Telomere Length and Telomerase Activity Are Associated With COPD and Lung Function

ATS 2023 • Washington, DC